Get started
Turn Therapeutics Inc.Turn Therapeutics Inc.Turn Therapeutics Inc.

Turn Therapeutics Inc.

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsOptionsETFs
Full chart
Full chart

Compare with Turn Therapeutics Inc.



Key stats


Market capitalization
‪397.07 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.29 USD
Net income (FY)
‪−3.19 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪10.79 M‬
Beta (1Y)
0.27

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Employees


Employees (FY)
2
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.60 M‬ USD

Company info


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Bradley Burnam
Website
turntherapeutics.com
Headquarters
Westlake Village
Founded
2015
IPO date
Oct 8, 2025
ISIN
US90021W1053
CUSIP
90021W105
FIGI
BBG002QTLH75
Identifiers
ISIN US90021W1053
CFI code
ESVUFR
Turn Therapeutics, Inc. is a pharmaceutical and medical device development company. Its primary development programs focus on dermatological diseases. The company was founded by Bradley Burnam on January 6, 2015 and is headquartered in Westlake Village, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Technicals


Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral

Analyst rating


An aggregate view of professional's ratings.
Neutral
Neutral
Neutral

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


IWC
iShares Microcap ETF
Weight0.04%
Market value‪583.37 K‬
BUSM
EA Bridgeway Ultra-Small Company Market ETF
Weight0.11%
Market value‪131.80 K‬

Explore more ETFs 

Frequently asked questions


The current price of TTRX is 13.33 USD — it has increased by 0.15% in the past 24 hours. Watch Turn Therapeutics Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Turn Therapeutics Inc. stocks are traded under the ticker TTRX.
TTRX stock has risen by 0.68% compared to the previous week, the month change is a 37.42% rise, over the last year Turn Therapeutics Inc. has showed a 33.30% increase.
We've gathered analysts' opinions on Turn Therapeutics Inc. future price: according to them, TTRX price has a max estimate of 26.00 USD and a min estimate of 10.00 USD. Watch TTRX chart and read a more detailed Turn Therapeutics Inc. stock forecast: see what analysts think of Turn Therapeutics Inc. and suggest that you do with its stocks.
TTRX reached its all-time high on Oct 9, 2025 with the price of 26.50 USD, and its all-time low was 2.57 USD and was reached on Nov 20, 2025. View more price dynamics on TTRX chart.
See other stocks reaching their highest and lowest prices.
TTRX stock is 10.76% volatile and has beta coefficient of 0.27. Track Turn Therapeutics Inc. stock price on the chart and check out the list of the most volatile stocks — is Turn Therapeutics Inc. there?
Today Turn Therapeutics Inc. has the market capitalization of ‪397.07 M‬, it has decreased by −14.72% over the last week.
Yes, you can track Turn Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
Turn Therapeutics Inc. is going to release the next earnings report on Nov 12, 2026. Keep track of upcoming events with our Earnings Calendar.
TTRX earnings for the last quarter are −0.20 USD per share, whereas the estimation was −0.02 USD resulting in a −900.00% surprise. The estimated earnings for the next quarter are −0.09 USD per share. See more details about Turn Therapeutics Inc. earnings.
TTRX net income for the last quarter is ‪−5.85 M‬ USD, while the quarter before that showed ‪−970.97 K‬ USD of net income which accounts for 0.00% change. Track more Turn Therapeutics Inc. financial stats to get the full picture.
No, TTRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 5, 2026, the company has 2 employees. See our rating of the largest employees — is Turn Therapeutics Inc. on this list?
Like other stocks, TTRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Turn Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Turn Therapeutics Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Turn Therapeutics Inc. stock shows the neutral signal. See more of Turn Therapeutics Inc. technicals for a more comprehensive analysis.